E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E7	Observation:T7 Name:T8 Numeric-Filter:E24 Severity:T80
E9	Observation:T9 Name:T10 Numeric-Filter:E27
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Condition:T17 Name:T18 Temporality:E81
E21	Procedure:T21 Name:T22 Temporality:E84
E22	Age:T42 Numeric-Filter:E23
E23	Eq-Comparison:T57 Operator:T23 Temporal-Unit:T34 Value:T43
E24	Eq-Comparison:T58 Operator:T24 Value:T44
E25	Eq-Comparison:T59 Operator:T25 Temporal-Unit:T35 Value:T47
E26	Eq-Comparison:T60 Operator:T26 Unit:T39 Value:T48
E27	Eq-Comparison:T61 Operator:T27 Unit:T40 Value:T49 Unit2:T110 Operator2:T177
E28	Eq-Comparison:T62 Operator:T28 Value:T50 Unit:T123
E29	Eq-Comparison:T63 Operator:T29 Temporal-Unit:T36 Value:T51
E30	Eq-Comparison:T64 Operator:T30 Temporal-Unit:T37 Value:T52
E31	Eq-Comparison:T65 Operator:T31 Value:T53 Unit:T141 Per:T142
E32	Eq-Comparison:T66 Operator:T32 Value:T54 Unit:T147 Per:T41
E5	Condition:T69 Name:T70 Severity:T73 Temporality:E8
E8	Eq-Comparison:T74 Temporal-Period:T75
E10	Observation:T76 Name:T77
E12	Study:T78 
E14	Modifier:T45 Modifies:T8
E18	Study:T81 
E33	Eq-Comparison:T46 Temporal-Recency:T83
E34	Eq-Comparison:T84 Temporal-Period:T85
E35	Condition:T86 Name:T87 Temporality:E34 Temporality2:E33 Temporality3:E25
E36	Study:T88 
E38	Condition:T90 Name:T91 Severity:T94 Temporality:E39
E39	Eq-Comparison:T92 Temporal-Period:T93
E11	Condition:T11 Name:T12
E41	Negation:T97 Negates:E11
E42	Observation:T98 Name:T99 Stability:T100
E44	Criteria-Count:T102 Min-Value:E88 Criteria:E45 Criteria2:E46 Criteria3:E9 Criteria4:E48
E45	Observation:T103 Name:T104 Numeric-Filter:E26
E46	Condition:T105 Name:T106 Severity:T107
E48	Condition:T111 Name:T112
E49	Modifier:T113 Modifies:T112
E50	Modifier:T114 Modifies:T112
E53	Drug:T117 Name:T118 Dose:E28 Temporality:E29
E54	Modifier:T119 Modifies:E53
E55	Modifier:T120 
E56	Modifier:T121 Modifies:E53
E58	Drug:T124 Name:T125
E59	Condition:T126 Name:T127
E60	Study:T128 
E62	Drug:T130 Name:T131 Temporality:E30
E63	Drug:T132 Name:T133 Temporality:E30
E64	Drug:T134 Name:T135 Temporality:E30
E66	Study:T137 
E68	Observation:T139 Name:T140 Numeric-Filter:E31
E69	Study:T143 
E71	Observation:T145 Name:T146 Numeric-Filter:E32
E72	Study:T148 
E74	Observation:T150 Name:T151 Polarity:T152
E19	Eq-Comparison:T19 Value:T20 Unit:T55
E75	Observation:T153 Name:T154 Numeric-Filter:E19
E76	Condition:T155 Name:T156 Temporality:E77
E77	Eq-Comparison:T157 Temporal-Recency:T158
E78	Condition:T159 Name:T160 Temporality:E77
E80	Modifier:T162 Modifies:T18
E81	Eq-Comparison:T163 Operator:T33 Temporal-Period:T164 Value:T56 Temporal-Unit:T38
E82	Study:T165 
E84	Eq-Comparison:T167 Temporal-Period:T168
E85	Condition:T169 Name:T170
E86	Procedure:T171 Name:T172 Temporality:E84
E88	Eq-Comparison:T174 Value:T175 Operator:T176
E89	Modifier:T178 Modifies:E75
T1	Condition 86 101	Graves' disease
T2	Condition-Name 86 101	Graves' disease
T3	Condition 107 122	hyperthyroidism
T4	Condition-Name 107 122	hyperthyroidism
T5	Life-Stage-And-Gender 33 39	female
T6	Life-Stage-And-Gender 25 29	Male
T7	Observation 201 204	CAS
T8	Observation-Name 201 204	CAS
T9	Observation 595 604	proptosis
T10	Observation-Name 595 604	proptosis
T13	Condition 1021 1037	immunomodulation
T14	Condition-Name 1021 1037	immunomodulation
T15	Condition 1254 1270	optic neuropathy
T16	Condition-Name 1254 1270	optic neuropathy
T17	Condition 1393 1404	optic nerve
T18	Condition-Name 1393 1404	optic nerve
T21	Procedure 1470 1489	orbital irradiation
T22	Procedure-Name 1470 1489	orbital irradiation
T23	Eq-Operator 40 41	≥
T24	Eq-Operator 206 207	≥
T25	Eq-Operator 341 347	within
T26	Eq-Operator 543 544	≥
T27	Eq-Operator 605 606	≥
T28	Eq-Operator 867 868	≥
T29	Eq-Operator 919 925	within
T30	Eq-Operator 1038 1053	within the past
T31	Eq-Operator 1103 1104	<
T32	Eq-Operator 1155 1156	<
T33	Eq-Operator 1417 1423	within
T34	Eq-Temporal-Unit 45 50	years
T35	Eq-Temporal-Unit 350 356	months
T36	Eq-Temporal-Unit 928 933	weeks
T37	Eq-Temporal-Unit 1056 1062	months
T38	Eq-Temporal-Unit 1435 1441	months
T39	Eq-Unit 547 549	mm
T40	Eq-Unit 609 611	mm
T41	Eq-Unit 1167 1170	mm3
T42	Age 54 57	age
T43	Eq-Value 42 44	18
T44	Eq-Value 208 209	4
T47	Eq-Value 348 349	9
T48	Eq-Value 545 546	2
T49	Eq-Value 607 608	3
T50	Eq-Value 869 870	1
T51	Eq-Value 926 927	3
T52	Eq-Value 1054 1055	9
T53	Eq-Value 1105 1106	6
T54	Eq-Value 1156 1160	1500
T56	Eq-Value 1433 1434	6
T57	Eq-Comparison 40 50	≥ 18 years
T58	Eq-Comparison 206 209	≥ 4
T59	Eq-Comparison 341 356	within 9 months
T60	Eq-Comparison 543 549	≥ 2 mm
T61	Eq-Comparison 605 624	≥ 3 mm above normal
T62	Eq-Comparison 867 872	≥ 1 g
T63	Eq-Comparison 919 933	within 3 weeks
T64	Eq-Comparison 1038 1062	within the past 9 months
T65	Eq-Comparison 1103 1109	< 6g/L
T66	Eq-Comparison 1155 1170	<1500 cells/mm3
T69	Condition 166 168	GO
T70	Condition-Name 166 168	GO
T72	Severity 147 155	moderate
T73	Severity 159 165	severe
T74	Eq-Comparison 139 145	active
T75	Eq-Temporal-Period 139 145	active
T76	Observation 176 199	Clinical Activity Score
T77	Observation-Name 176 199	Clinical Activity Score
T78	Study 248 257	Screening
T80	Severity 223 231	severely
T45	Modifier 232 244	affected eye
T81	Study 284 292	Baseline
T46	Eq-Comparison 322 327	Onset
T83	Eq-Temporal-Recency 322 327	Onset
T84	Eq-Comparison 331 337	active
T85	Eq-Temporal-Period 331 337	active
T86	Condition 338 340	GO
T87	Condition-Name 338 340	GO
T88	Study 360 369	screening
T90	Condition 402 404	GO
T91	Condition-Name 402 404	GO
T92	Eq-Comparison 395 401	active
T93	Eq-Temporal-Period 395 401	active
T94	Severity 388 394	severe
T95	Severity 376 384	Moderate
T11	Condition 410 427	sight-threatening
T12	Condition-Name 410 427	sight-threatening
T97	Negation 406 409	not
T98	Observation 461 471	daily life
T99	Observation-Name 461 471	daily life
T100	Stability 451 457	impact
T102	Criteria-Count 513 526	the following
T103	Observation 528 542	lid retraction
T104	Observation-Name 528 542	lid retraction
T105	Condition 570 593	soft tissue involvement
T106	Condition-Name 570 593	soft tissue involvement
T107	Severity 563 569	severe
T108	Severity 551 559	moderate
T110	Eq-Unit 618 624	normal
T111	Condition 676 684	diplopia
T112	Condition-Name 676 684	diplopia
T113	Modifier 667 675	constant
T114	Modifier 653 663	inconstant
T117	Drug 795 802	steroid
T118	Drug-Name 795 802	steroid
T119	Modifier 804 815	intravenous
T120	Modifier 817 819	IV
T121	Modifier 824 828	oral
T123	Eq-Unit 871 872	g
T124	Drug 876 894	methylprednisolone
T125	Drug-Name 876 894	methylprednisolone
T126	Condition 916 918	GO
T127	Condition-Name 916 918	GO
T128	Study 943 952	Screening
T130	Drug 966 975	rituximab
T131	Drug-Name 966 975	rituximab
T132	Drug 977 988	tocilizumab
T133	Drug-Name 977 988	tocilizumab
T134	Drug 997 1016	monoclonal antibody
T135	Drug-Name 997 1016	monoclonal antibody
T137	Study 1072 1080	Baseline
T139	Observation 1087 1102	Total IgG level
T140	Observation-Name 1087 1102	Total IgG level
T141	Eq-Unit 1106 1107	g
T142	Eq-Unit 1108 1109	L
T143	Study 1113 1122	Screening
T145	Observation 1129 1154	Absolute neutrophil count
T146	Observation-Name 1129 1154	Absolute neutrophil count
T147	Eq-Unit 1161 1166	cells
T148	Study 1174 1183	Screening
T150	Observation 1218 1246	best corrected visual acuity
T151	Observation-Name 1218 1246	best corrected visual acuity
T152	Polarity 1208 1217	decreased
T19	Eq-Comparison 1309 1316	2 lines
T20	Eq-Value 1309 1310	2
T55	Eq-Unit 1311 1316	lines
T153	Observation 1287 1305	decrease in vision
T154	Observation-Name 1287 1305	decrease in vision
T155	Condition 1343 1362	visual field defect
T156	Condition-Name 1343 1362	visual field defect
T157	Eq-Comparison 1339 1342	new
T158	Eq-Temporal-Recency 1339 1342	new
T159	Condition 1367 1379	color defect
T160	Condition-Name 1367 1379	color defect
T162	Modifier 1405 1416	involvement
T163	Eq-Comparison 1417 1441	within the last 6 months
T164	Eq-Temporal-Period 1428 1432	last
T165	Study 1445 1454	Screening
T167	Eq-Comparison 1461 1469	Previous
T168	Eq-Temporal-Period 1461 1469	Previous
T169	Condition 1505 1507	GO
T170	Condition-Name 1505 1507	GO
T171	Procedure 1493 1500	surgery
T172	Procedure-Name 1493 1500	surgery
T174	Eq-Comparison 498 509	one or more
T175	Eq-Value 498 501	one
T176	Eq-Operator 502 509	or more
T177	Eq-Operator 612 617	above
T178	Modifier 1324 1337	Snellen chart
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T6 male
A3	Eq-Operator-Value T23 GTEQ
A4	Eq-Operator-Value T24 GTEQ
A5	Eq-Operator-Value T25 LTEQ
A6	Eq-Operator-Value T26 GTEQ
A7	Eq-Operator-Value T27 GTEQ
A8	Eq-Operator-Value T28 GTEQ
A9	Eq-Operator-Value T29 LTEQ
A10	Eq-Operator-Value T30 LTEQ
A11	Eq-Operator-Value T31 LT
A12	Eq-Operator-Value T32 LT
A13	Eq-Operator-Value T33 LTEQ
A14	Eq-Temporal-Unit-Value T34 year
A15	Eq-Temporal-Unit-Value T35 month
A16	Eq-Temporal-Unit-Value T36 week
A17	Eq-Temporal-Unit-Value T37 month
A18	Eq-Temporal-Unit-Value T38 month
A19	Severity-Value T72 moderate
A20	Severity-Value T73 severe
A21	Eq-Temporal-Period-Value T75 present
A22	Observation-Type-Value E10 clinical-score
A23	Severity-Value T80 severe
A25	Eq-Temporal-Recency-Value T83 first-time
A26	Eq-Temporal-Period-Value T85 present
A28	Eq-Temporal-Period-Value T93 present
A29	Severity-Value T94 severe
A30	Severity-Value T95 severe
A31	Stability-Value T100 change
A32	Observation-Type-Value E45 measurement
A33	Severity-Value T107 severe
A34	Severity-Value T108 moderate
A35	Eq-Unit-Value T110 ref-range-normal
A38	Observation-Type-Value E68 lab
A40	Observation-Type-Value E71 lab
A42	Polarity-Value T152 low
A43	Observation-Type-Value E75 measurement
A44	Eq-Temporal-Recency-Value T158 first-time
A45	Eq-Temporal-Period-Value T164 past
A47	Eq-Temporal-Period-Value T168 past
A48	Eq-Operator-Value T176 GTEQ
A49	Eq-Operator-Value T177 GT
R1	Caused-By Arg1:E3 Arg2:E5
R2	Abbrev-Of Arg1:E7 Arg2:E10
R4	Caused-By Arg1:E11 Arg2:E38
R3	Caused-By Arg1:T100 Arg2:E38
R9	Abbrev-Of Arg1:E55 Arg2:E54
R10	Example-Of Arg1:E58 Arg2:E53
R11	Treatment-For Arg1:E53 Arg2:E59
R12	Treatment-For Arg1:E64 Arg2:E13
R13	Caused-By Arg1:E74 Arg2:E15
R14	Equivalent-To Arg1:E75 Arg2:E15
R15	Equivalent-To Arg1:E76 Arg2:E15
R16	Caused-By Arg1:E78 Arg2:E17
R17	Equivalent-To Arg1:E17 Arg2:E15
R18	Treatment-For Arg1:E86 Arg2:E85
R5	Equivalent-To Arg1:E44 Arg2:E38
R6	Treatment-For Arg1:E63 Arg2:E13
R7	Treatment-For Arg1:E62 Arg2:E13
R8	Treatment-For Arg1:E21 Arg2:E85
R19	Or Arg1:T6 Arg2:T5
R20	And Arg1:E1 Arg2:E3
R21	Or Arg1:T72 Arg2:T73
R22	During Arg1:E7 Arg2:E12
R23	And Arg1:E12 Arg2:E18
R24	Before Arg1:E25 Arg2:E36
R25	Or Arg1:T95 Arg2:T94
R26	And Arg1:E41 Arg2:E42
R27	Or Arg1:T108 Arg2:T107
R28	Or Arg1:E50 Arg2:E49
R29	Or Arg1:E9 Arg2:E48
R30	Or Arg1:E55 Arg2:E56
R31	Before Arg1:E29 Arg2:E60
R32	Or Arg1:E63 Arg2:E64
R33	Before Arg1:E30 Arg2:E66
R34	During Arg1:E68 Arg2:E69
R35	During Arg1:E71 Arg2:E72
R36	Or Arg1:E76 Arg2:E78
R37	During Arg1:E17 Arg2:E82
R38	Or Arg1:E21 Arg2:E86
R39	Or Arg1:E46 Arg2:E9
R40	Or Arg1:E62 Arg2:E63
